Trial intelligence / Profile preview

Pantoprazole vs Famotidine for Peptic Ulcer Prevention in Thienopyridine Users

NCT02551744Completed

Sponsor
Kaohsiung Veterans General Hospital
Start
Jul 2012
Primary completion
Jul 2018
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of famotidine in peptic ulcer disease (PUD) (2 arms), sponsored by Kaohsiung Veterans General Hospital. Primary endpoint: Number of Participants With Ulcer Recurrence at 6 months. Started Jul 2012; status: completed.

02

Drugs

famotidine
03

Conditions

peptic ulcer disease (PUD)

Beyond the preview

Go deeper on NCT02551744.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02551744.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call